Human alpha-glucosidase: Phase I/II data; Phase II

GENZ and partner Pharming Group N.V.(PHAR; EASDAQ:PHAR, Leiden, the Netherlands) published in Genetics in Medicine previously reported interim results from an ongoing U.S. open-label Phase I/II trial...